Latest Psychedelic Science Research Papers

2 days ago • Addiction (Abingdon, England)

Mental changes in alcohol use disorder linked to 5-MeO-DMT and cognitive behavioral therapyPsychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.

🥉 Top 5% JournalArticle

2 days ago • Journal of pain and symptom management

Safety and Effectiveness of Psilocybin During Cancer Treatment: Analysis of a Phase II TrialSafety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.

Article

2 days ago • The Psychiatric clinics of North America

Building Skills with Psychedelic Therapy While Addressing Social Health FactorsCapacity Building Through Psychedelic-Assisted Therapy: Navigating Social Determinants of Health.

Article

2 days ago • Journal of psychopharmacology (Oxford, England)

Finding the best dose for psychedelics to reduce fear in rodent studiesWhere is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.

Article

4 days ago • Metabolic engineering communications

Rebuilding the two-step process that bacteria use to make DMTReconstituting a two-step pathway for N,N-dimethyltryptamine (DMT) biosynthesis in bacteria.

📖 Top 20% JournalArticle

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

How Canadian Veterans Find and View Psychedelic Treatments: Routes and ChallengesExploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions.

Article

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

Nurses' Opinions on Legalizing Psychedelic DrugsPredicting Nurses' Views on Decriminalization of Psychedelics.

Article

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

Nature Videos Increase Connection to Nature During Psilocybin Therapy for Alcohol Use DisorderA Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.

Article

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

Psychiatrists' Preparedness to Use Psilocybin in Treatment in Louisiana, a State with Little Psychedelic ResearchAssessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.

Article

4 days ago • Progress in neuro-psychopharmacology & biological psychiatry

How Fast Breathing Changes Consciousness: Reduced Blood Flow, Brain Network Activity, and Personal ExperienceHow high ventilation breathwork alters consciousness: Hypoperfusion, network dynamics, and subjective experience.

Article

4 days ago • Frontiers in psychiatry

Ketamine and its effects on substance use disorders: a combined review and analysisKetamine for substance use disorders: a systematic review and meta-analysis.

📖 Top 20% JournalSystematic Review

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

Group Psilocybin Therapy for People with Advanced Cancer and Anxiety or Depression Using a Rite of Passage Approach in an Early-Stage StudyGroup Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.

Article

4 days ago • bioRxiv : the preprint server for biology

Psilocybin unevenly changes decision-making and brain processing when outcomes are uncertainPsilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty.

Preprint

4 days ago • Focus (American Psychiatric Publishing)

Current Evidence and Medical Use of Ketamine and Esketamine in ChildrenUse of Ketamine and Esketamine in the Pediatric Population: Current Evidence and Clinical Applications.

Article

4 days ago • bioRxiv : the preprint server for biology

Psychedelic drugs affect nerve cell branches differently depending on behavior and serotonin receptorsPsychedelic drug action at dendrites is gated by behavioral state and serotonin receptors.

Preprint

4 days ago • Research square

Ketamine stays inside nerve cells long after it leaves the bloodstreamKetamine persists within neuronal compartments long after systemic clearance.

Preprint

4 days ago • Focus (American Psychiatric Publishing)

New Uses of Ketamine and Esketamine for Treating Mental Health DisordersEmerging Clinical Applications of Ketamine and Esketamine Across Psychiatric Disorders.

Article

4 days ago • Focus (American Psychiatric Publishing)

Psilocybin's potential to treat mental health disorders: how it works, effectiveness, and medical usesTherapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications.

Article

4 days ago • bioRxiv : the preprint server for biology

"Dark magic mushroom" produces both deadly toxins and psychedelic compoundsThe "dark magic mushroom" co-produces amatoxins and psilocybin.

Preprint

5 days ago • Journal of military, veteran and family health

Review of a psychiatric outpatient therapy program using ketamine across different diagnosesA retrospective report of a ketamine-augmented, transdiagnostic psychiatric outpatient psychotherapy program.

📖 Top 50% JournalArticle

5 days ago • European journal of clinical pharmacology

Heart safety of psilocybin use in mental health treatment: a reviewCardiovascular safety of psilocybin in psychiatric practice: a narrative review.

📖 Top 20% JournalArticle

6 days ago • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Ongoing Challenges in Treating Hard-to-Treat Depression After Ketamine's Initial EffectsTreatment-resistant Depression in the Post-ketamine Era: Unmet Needs beyond Rapid Response.

📖 Top 20% JournalArticle

6 days ago • Frontiers in psychiatry

How psychedelic drugs affect male and female rodents differently: a review of studiesSex-dependent effects of psychedelics: review of evidence from rodent models.

📖 Top 20% JournalArticle

6 days ago • Journal of psychiatric research

Dissociation and antidepressant response to under-the-skin esketamine treatmentDissociation and antidepressant response to subcutaneous esketamine: A clinical study.

Article

6 days ago • medRxiv : the preprint server for health sciences

Psilocybin with early palliative care for feelings of hopelessness and long-term pain: a preliminary open studyPsilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.

Preprint

6 days ago • Communications medicine

Safety, practicality, and early results of psilocybin therapy for veterans with severe, hard-to-treat PTSDSafety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial.

🥉 Top 5% JournalArticle

1 week ago • Psychedelic medicine (New Rochelle, N.Y.)

Natural psychedelic use and support for partisan violence may change after major political eventsPolitically Salient Events May Modulate Effects of Naturalistic Psychedelic Use on Support for Partisan Violence.

Article

1 week ago • Molecular psychiatry

Shared brain-immune signaling linked to fast antidepressant effects of ketamine and psychedelicsConvergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.

🥈 Top 2% JournalArticle

1 week ago • Trends in psychiatry and psychotherapy

Testing if ibogaine is safe and helpful for people with moderate to severe alcohol addictionFeasibility, safety and preliminary effects of ibogaine in patients with moderate and severe alcohol use disorder: a pilot, open-label study.

📖 Top 30% JournalArticle

1 week ago • Molecular neurobiology

Possible Biological Signs of Bipolar Disorder Progression and Their Links to Ketamine and Psychedelic TreatmentsCandidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

🎖️ Top 10% JournalArticle

← prevpage 1 of 4next →